Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Cabozantinib for Thyroid Cancer
Recruiting3 awardsPhase 3
Cincinnati, Ohio
This trial is testing whether a new drug called cabozantinib is better than placebo at treating patients with a certain type of thyroid cancer that has progressed after other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service